Chief Strategy Officer
In September 2015, Mr. Gosebruch became Chief Strategy Officer of long-time client, pharmaceutical company AbbVie Inc.
In March 2015, Mr Gosebruch had been named J.P. Morgan's Co-Head of Mergers & Acquisitions in North America. Previously, Mr. Gosebruch was a Managing Director in J.P. Morgan's Mergers & Acquisitions Group. Mr. Gosebruch had transaction expertise in several sectors but spent a significant portion of his time in the pharma/biotech sector. Mr. Gosebruch also served on J.P. Morgan's fairness committee and as J.P. Morgan M&A engagements officer for North America.
Mr. Gosebruch is a German citizen and joined J.P. Morgan's M&A Group in New York in 1995 as a graduate of the Wharton School of the University of Pennsylvania where he was a Benjamin Franklin Scholar. In October 2007, at age 34, he was selected by the New York Times for its Face Book of Wall Street's Future listing 100 bankers, lawyers, and investors. In September 2008, at age 35, he was selected by Dealmaker Magazine in its Top 40 Under 40. He has also been featured in the Financial Times and Bloomberg and has spoken at the Bloomberg Dealmaker Summit. In 2010 and 2011 he was selected to serve on the faculty of the Practising Law Institute (PLI) regarding cutting edge M&A structures.
Mr. Gosebruch and his wife reside in New York City and have three sons.